Cargando…
Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review
The ovarian cancer recurrence occurs in 75% of patients with advanced FIGO stage, and its treatment is a challenge for the oncologist in gynecology. The standard treatment of recurrent ovarian cancer (ROC) usually includes intravenous chemotherapy according to platinum sensitivity. Furthermore, main...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039681/ https://www.ncbi.nlm.nih.gov/pubmed/33850907 http://dx.doi.org/10.21037/atm-20-4690 |